Trial Profile
Effect of early heart rate control by ivabradine on left ventricular remodeling after primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2017
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 31 Oct 2017 New trial record